Pain Therapeutics’ Remoxy Approval Hinges On REMS; FDA Unsure If Drug Is Abuse-Resistant

FDA’s Anesthetic and Life Support Drugs and Drug Safety and Risk Management Advisory Committees will discuss whether the proposed REMS can adequately determine abuse of the opioid.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet